HDAC AND PI3K ANTAGONISTS COOPERATE TO INHIBIT GROWTH OF MYC-DRIVEN MEDULLOBLASTOMA

被引：0
|
作者：
Liu, Kun-Wei [1 ]
Pei, Yanxin [1 ,2 ]
Wechsler-Reya, Robert [1 ]
机构：
[1] Sanford Burnham Med Res Inst, La Jolla, CA USA
[2] Childrens Natl Med Ctr, Washington, DC 20010 USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MB-13
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] Novel glutamine antagonist JHU-395 suppresses MYC-driven medulloblastoma growth and induces apoptosis
    Khoa Pham
    Maxwell, Micah
    Sweeney, Heather
    Alt, Jesse
    Rais, Rana
    Slusher, Barbara S.
    Eberhart, Charles G.
    Raabe, Eric H.
    CANCER RESEARCH, 2020, 80 (16)
  • [22] DUAL TARGETING OF PI3K AND mTOR SIGNALING IN MEDULLOBLASTOMA
    Clymer, Jessica
    Eckerdt, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2016, 18 : 112 - 112
  • [23] Development of an HDAC/PI3K dual inhibitor in academia
    Saijo, Ken
    Ishioka, Chikashi
    ANNALS OF ONCOLOGY, 2017, 28 : 49 - 49
  • [24] ROLE OF THE let7-eEF2K AXIS IN MYC-DRIVEN MEDULLOBLASTOMA ADAPTATION TO NUTRIENT DEPRIVATION
    Delaidelli, Alberto
    Negri, Gian Luca
    Sidhu, Simran
    Remke, Marc
    Pfister, Stefan
    Taylor, Michael
    Leprivier, Gabriel
    Kool, Marcel
    Sorensen, Poul
    NEURO-ONCOLOGY, 2018, 20 : 33 - 33
  • [25] JMJD6 as a novel tumorigenic factor and therapeutic target in group 3 (MYC-driven) medulloblastoma
    Kling, Matthew
    Kumar, Devendra
    Ray, Sutapa
    Joshi, Shantaram
    Coulter, Don
    Chaturvedi, Nagendra K.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
    Kling, Matthew J.
    Kesherwani, Varun
    Mishra, Nitish K.
    Alexander, Gracey
    McIntyre, Erin M.
    Ray, Sutapa
    Challagundla, Kishore B.
    Joshi, Shantaram S.
    Coulter, Don W.
    Chaturvedi, Nagendra K.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [27] Small molecule inhibitors of PI3K/Akt signaling inhibit WntA#946;-catenin pathway crosstalk and suppress medulloblastoma growth
    Ninib, Baryawno
    Sveinbjornsson, Baldur
    Eksborg, Staffan
    Chen, Ching-Shih
    Kogner, Per
    Johnsen, John-Inge
    CANCER RESEARCH, 2009, 69
  • [28] A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma
    Chaturvedi, Nagendra K.
    Kling, Matthew J.
    Griggs, Connor N.
    Kesherwani, Varun
    Shukla, Mamta
    McIntyre, Erin M.
    Ray, Sutapa
    Liu, Yutong
    McGuire, Timothy R.
    Sharp, J. Graham
    Band, Hamid
    Joshi, Shantaram S.
    Coulter, Don W.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (06) : 1351 - 1362
  • [29] A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
    Matthew J. Kling
    Varun Kesherwani
    Nitish K. Mishra
    Gracey Alexander
    Erin M. McIntyre
    Sutapa Ray
    Kishore B. Challagundla
    Shantaram S. Joshi
    Don W. Coulter
    Nagendra K. Chaturvedi
    Journal of Experimental & Clinical Cancer Research, 41
  • [30] Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
    Oh, Danielle H.
    Ma, Xiao
    Hogg, Simon J.
    He, Jackson
    Kearney, Conor
    Brasacchio, Daniella
    Susanto, Olivia
    Maher, Belinda
    Jennings, Ian G.
    Newbold, Andrea
    Fraser, Peter
    Gruber, Emily
    Kats, Lev M.
    Gregory, Gareth P.
    Johnstone, Ricky W.
    Thompson, Philip E.
    Shortt, Jake
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (36)
12345